Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

105 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Clinical and biochemical evolution after partial dietary liberalization of two cases of galactosemia due to galactose mutarotase deficiency.
Sánchez-Pintos P, Camba-Garea MJ, López-Pardo BM, de Juan JAC, Bóveda MD, Barbosa-Gouveia S, Vázquez-Mosquera ME, Barros-Angueira F, Patiño RF, Couce ML. Sánchez-Pintos P, et al. Among authors: de juan jac. BMC Pediatr. 2024 Sep 30;24(1):620. doi: 10.1186/s12887-024-05074-6. BMC Pediatr. 2024. PMID: 39350089 Free PMC article.
Complete vs. incomplete percutaneous revascularization in patients with chronic total coronary artery occlusion.
Maestre-Luque LC, Gonzalez-Manzanares R, Suárez de Lezo J, Hidalgo F, Barreiro-Mesa L, de Juan J, Gallo I, Perea J, Alvarado M, Romero M, Ojeda S, Pan M. Maestre-Luque LC, et al. Among authors: de juan j. Front Cardiovasc Med. 2024 Jul 23;11:1443258. doi: 10.3389/fcvm.2024.1443258. eCollection 2024. Front Cardiovasc Med. 2024. PMID: 39108670 Free PMC article.
Repetitive levosimendan infusions for patients with advanced chronic heart failure in the vulnerable post-discharge period: The multinational randomized LeoDOR trial.
Pölzl G, Altenberger J, Comín-Colet J, Delgado JF, Fedele F, García-González MJ, Gustafsson F, Masip J, Papp Z, Störk S, Ulmer H, Maier S, Vrtovec B, Wikström G, Zima E, Bauer A; LeoDOR Investigators. Pölzl G, et al. Eur J Heart Fail. 2023 Nov;25(11):2007-2017. doi: 10.1002/ejhf.3006. Epub 2023 Sep 4. Eur J Heart Fail. 2023. PMID: 37634941 Free article. Clinical Trial.
Characteristics of hepatitis C virus resistance in an international cohort after a decade of direct-acting antivirals.
Howe AYM, Rodrigo C, Cunningham EB, Douglas MW, Dietz J, Grebely J, Popping S, Sfalcin JA, Parczewski M, Sarrazin C, de Salazar A, Fuentes A, Sayan M, Quer J, Kjellin M, Kileng H, Mor O, Lennerstrand J, Fourati S, Di Maio VC, Chulanov V, Pawlotsky JM, Harrigan PR, Ceccherini-Silberstein F, Garcia F; SHARED Collaborators. Howe AYM, et al. JHEP Rep. 2022 Feb 24;4(5):100462. doi: 10.1016/j.jhepr.2022.100462. eCollection 2022 May. JHEP Rep. 2022. PMID: 35434589 Free PMC article.
Optimisation in the multidisciplinary approach to patients with hepatitis C in the era of direct-acting antivirals.
Calleja JL, Bermúdez Á, Camacho Á, Cárdenas F, Fernández S, de Juan J, Jorquera F, Linares M, Rodríguez MÁ, Romero M, Ruiz JJ, José Sánchez M, de la Vega J. Calleja JL, et al. Among authors: de juan j. Gastroenterol Hepatol. 2019 Sep;42 Suppl 1:8-13. doi: 10.1016/S0210-5705(20)30182-5. Epub 2020 Jun 16. Gastroenterol Hepatol. 2019. PMID: 32560771 English, Spanish.
105 results